Status:
COMPLETED
Evaluation of Antithrombin Deficiency in Patients of Intensive Care Unit Placed on Extracorporeal Membrane Oxygenation
Lead Sponsor:
Rennes University Hospital
Conditions:
Severe Cardiac Insufficiency
Eligibility:
All Genders
18+ years
Brief Summary
Prospective, monocentric, non-interventional study in patients placed on extracorporeal membrane oxygenation (ECMO)
Detailed Description
Our hypothesis is that ECMO initiation is responsible for a severe decrease of antithrombin level in a high proportion of patients who develop heparin resistance.
Eligibility Criteria
Inclusion
- Any ICU patient of receiving veno-arterial extracorporeal membrane oxygenation
- Patients who have not expressed opposition to participate
Exclusion
- Arterial thrombosis or progressive venous thrombosis
- Contraindication to heparin
- Constitutional deficiency in antithrombin
- Patient refusal
- Minor patient
- Protected major (safeguard justice, trusteeship and guardianship) and persons deprived of liberty
Key Trial Info
Start Date :
May 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 18 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04133844
Start Date
May 5 2020
End Date
May 18 2021
Last Update
June 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Rennes
Rennes, France, 35033